Pages that link to "Q37659128"

The following pages link to Peroxisome proliferator-activated receptor (PPAR) beta/delta: a new potential therapeutic target for the treatment of metabolic syndrome. (Q37659128):

Displaying 29 items.

• PPAR Ligands Function as Suppressors That Target Biological Actions of HMGB1 (Q26738811) (← links)
• An ethanol extract of Artemisia iwayomogi activates PPARδ leading to activation of fatty acid oxidation in skeletal muscle (Q28730913) (← links)
• A novel model of cholesterol efflux from lipid-loaded cells (Q33577644) (← links)
• Peroxisome proliferator-activated receptors for hypertension (Q34179017) (← links)
• Assessment of chitosan-affected metabolic response by peroxisome proliferator-activated receptor bioluminescent imaging-guided transcriptomic analysis (Q34230420) (← links)
• β-Carotene Attenuates Angiotensin II-Induced Aortic Aneurysm by Alleviating Macrophage Recruitment in Apoe(-/-) Mice. (Q34796427) (← links)
• Selenoprotein-dependent up-regulation of hematopoietic prostaglandin D2 synthase in macrophages is mediated through the activation of peroxisome proliferator-activated receptor (PPAR) gamma. (Q35144923) (← links)
• Impaired sympathoadrenal axis function contributes to enhanced insulin secretion in prediabetic obese rats (Q35167806) (← links)
• A metabolomic study of the PPARδ agonist GW501516 for enhancing running endurance in Kunming mice (Q35574757) (← links)
• AMP-Activated Protein Kinase Interacts with the Peroxisome Proliferator-Activated Receptor Delta to Induce Genes Affecting Fatty Acid Oxidation in Human Macrophages (Q35670860) (← links)
• New targets to treat obesity and the metabolic syndrome (Q36068914) (← links)
• Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions (Q36261125) (← links)
• Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention? (Q36411656) (← links)
• MicroRNA-29a induces insulin resistance by targeting PPARδ in skeletal muscle cells (Q36684236) (← links)
• Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases (Q36918509) (← links)
• PPARs Integrate the Mammalian Clock and Energy Metabolism (Q37623758) (← links)
• Diabetes type II: a risk factor for depression-Parkinson-Alzheimer? (Q37765503) (← links)
• Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy (Q37817830) (← links)
• Potential new approaches to modifying intestinal GLP-1 secretion in patients with type 2 diabetes mellitus: focus on bile acid sequestrants (Q37940632) (← links)
• Role of PPAR γ in the Differentiation and Function of Neurons (Q38253356) (← links)
• Activation of PPARδ: from computer modelling to biological effects. (Q38254275) (← links)
• Peroxisome proliferator-activated receptors in cardiac energy metabolism and cardiovascular disease (Q38817895) (← links)
• Structural basis for PPAR partial or full activation revealed by a novel ligand binding mode (Q41343506) (← links)
• Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma. (Q41912809) (← links)
• Identification of Hepatic Lysophosphatidylcholine Acyltransferase 3 as a Novel Target Gene Regulated by Peroxisome Proliferator-activated Receptor δ. (Q44417767) (← links)
• Activation of peroxisome proliferator activator receptor delta in mouse impacts lipid composition and placental development at early stage of gestation (Q50656221) (← links)
• Improved methods for selective cryolipolysis results in subcutaneous fat layer reduction in a porcine model (Q51113410) (← links)
• Effects of Chios mastic gum and exercise on physical characteristics, blood lipid markers, insulin resistance, and hepatic function in healthy Japanese men. (Q64890903) (← links)
• Peroxisomes and Oxidative Stress: Their Implications in the Modulation of Cellular Immunity During Mycobacterial Infection. (Q65002704) (← links)